In many inflammatory skin disorders, DMKN is a promising epithelial development biomolecular tool for gene therapy by coordinating various signaling pathways like TP53, PI3K/Akt, and TGF-β pathways [15,69]. Here, TP53 is linked to inflammatory skin disease.